Costs of drug-related morbidity and mortality: enormous and growing rapidly

D W Bates¹

Affiliations

¹ Department of Medicine, Brigham and Women's Hospital, and the Center for Applied Medical Information Systems Research, Boston, Massachusetts, USA. dbates@partners.org

Comment

D W Bates. J Am Pharm Assoc (Wash). 2001 Mar-Apr.

. 2001 Mar-Apr;41(2):156-7.

doi: 10.1016/s1086-5802(16)31242-6.

D W Bates¹

¹ Department of Medicine, Brigham and Women's Hospital, and the Center for Applied Medical Information Systems Research, Boston, Massachusetts, USA. dbates@partners.org

No abstract available

Comment on

Drug-related morbidity and mortality: updating the cost-of-illness model.
Ernst FR, Grizzle AJ. Ernst FR, et al. J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):192-9. doi: 10.1016/s1086-5802(16)31229-3. J Am Pharm Assoc (Wash). 2001. PMID: 11297331